Mast Therapeutics, Inc.
Biotechnology ResearchView the employees at
Mast Therapeutics, Inc.-
Masud Islam Managing Director at Mast Therapeutics, Inc.
-
Bangladesh
-
Rising Star
Marsha Grader Senior Consultant at Mast Therapeutics, Inc.-
Bayport, Minnesota, United States
-
Rising Star
Don DeRoo Sr. Director, Quality Assurance at ADVENTRX Pharmaceuticals-
Connecticut, Statele Unite Ale Americii
-
Rising Star
Rohan Schrapel Project Manager at Mast Therapeutics, Inc.-
Greater Adelaide Area
-
Rising Star
Overview
We are a biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. Through our acquisition of SynthRx, Inc. in 2011, we acquired our Membrane Adhesion & Sealant Technology (MAST) platform, which includes proprietary poloxamer-related data and know-how derived from over two decades of clinical, nonclinical and manufacturing experience, and we are leveraging the MAST platform to develop MST-188 for diseases and conditions characterized by microcirculatory insufficiency.
-